Mycoplasma pneumoniae: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
*Causes: | *Causes: | ||
**Pneumonia | **Pneumonia | ||
***Walking PNA, patchy and interstitial | |||
***Relative bradycardia | |||
**[[Bullous myringitis]] - painful, fluid filled vesicles on eardrum | **[[Bullous myringitis]] - painful, fluid filled vesicles on eardrum | ||
***Presence of otalgia should prompt evaluation | ***Presence of otalgia should prompt evaluation | ||
***(Streptococcus pneumoniae is also associated w/ bullous myringitis) | ***(Streptococcus pneumoniae is also associated w/ bullous myringitis) | ||
**[[Guillain-Barre Syndrome]] | |||
**Cold agglutinins w/ IgM | |||
**[[Erythema Multiforme]] | |||
**[[Encephalitis]] | |||
==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>== | ==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>== | ||
Revision as of 23:44, 3 June 2016
Background
- Typically affects patients <40yo
- Causes:
- Pneumonia
- Walking PNA, patchy and interstitial
- Relative bradycardia
- Bullous myringitis - painful, fluid filled vesicles on eardrum
- Presence of otalgia should prompt evaluation
- (Streptococcus pneumoniae is also associated w/ bullous myringitis)
- Guillain-Barre Syndrome
- Cold agglutinins w/ IgM
- Erythema Multiforme
- Encephalitis
- Pneumonia
Antibiotic Sensitivities[1]
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
Table Overview
| ||||||||||||||||||||||||||||||||||||||||
See Also
References
- ↑ Sanford Guide to Antimicrobial Therapy 2014